The US regulator has said that compounders can continue to trade in tirzepatide products while it undertakes a review to ...
A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...
Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no longer in shortage after nearly two years. Pharmacies that sold ...
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
The FDA decision will enable Antag Therapeutics to initiate the clinical development of its lead candidate drug, a ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
Thermo Fisher plant in North Carolina flagged for contamination, air bubble issues in FDA inspection
Thermo Fisher Scientific is responsible for helping to produce some of the hottest drugs on the market, including Novo ...
Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...
FDA faces legal action after removing Tirzepatide from the shortage list without following required procedures, sparking ...
The pharmaceutical industry has seen a tremendous surge in the development of weight loss drugs, particularly GLP-1 receptor ...
The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...
Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback